Frank W. Chan serves as Executive Vice President and Chief Operating Officer at Haemonetics Corp., where he oversees global operations, supply chain management, and strategic initiatives aimed at advancing the company's leadership in blood management and transfusion solutions. With more than 25 years of experience in the medical technology sector, Chan previously held senior roles at Baxter International and Medtronic, focusing on manufacturing optimization and international expansion that drove double-digit revenue growth in emerging markets. Throughout his career, Chan has been recognized for implementing lean manufacturing principles and digital transformation projects that enhanced operational efficiency and product quality across complex regulatory environments. His achievements include leading cross-functional teams in the successful integration of acquisitions and the launch of innovative plasma collection systems that improved patient outcomes and reduced costs for healthcare providers worldwide. In his current role at Haemonetics, Chan directs efforts to scale sustainable practices and accelerate R&D pipelines, ensuring the company's devices meet evolving clinical demands while maintaining rigorous compliance standards. He holds an MBA from the University of Chicago Booth School of Business and serves on industry advisory boards promoting advancements in hematology technologies.